Skip to content

Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients

Unknown statusNot applicableNCT06247592
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

In this study, the effect of nerve blockade and radiofrequency treatment applied to the nerve on pain in chronic migraine patients will be investigated. Occipital nerve blockade group (control group): Depending on the location of the pain, blockade will be applied unilaterally or bilaterally with 5 cc of 2% prilocaine for each sıde. Pulse Radiofrequency application to the greater occipital nerve will be applicated after radiofrequency cannula placed near the greater occipital nerve location with 42 degree, for 240 seconds.

Study details

Official title
Comparison of Greater Occipital Nerve Block and Pulse Radiofrequency in Patients With Chronic Migraine
Conditions
Interventions
  • Procedure: Greater occipital nerve block
  • Procedure: Greater occipital nerve pulse radiofrequency
Sponsor
Aydin Adnan Menderes University
Start date
2023-09-26
Primary completion
2024-03-10
Sex
All
Age range
from 18 Years to 60 Years
Results posted
No results posted in this snapshot
Countries
Turkey (Türkiye)
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients between 18-60 years of age diagnosed with chronic migraine according to IHS criteria Exclusion Criteria: * Pregnancy * Major psychiatric disorder * Bleeding diathesis * Local infection * Allergy

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06247592